ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 242 filers reported holding ACCELERON PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,752,000 | -94.6% | 21,796 | -96.1% | 0.00% | -95.5% |
| Q2 2021 | $69,559,000 | -7.4% | 554,274 | +0.1% | 0.02% | -12.0% |
| Q1 2021 | $75,089,000 | +5.6% | 553,708 | -0.4% | 0.02% | 0.0% |
| Q4 2020 | $71,119,000 | -23.6% | 555,882 | -32.8% | 0.02% | -34.2% |
| Q3 2020 | $93,052,000 | +149.6% | 826,914 | +111.3% | 0.04% | +137.5% |
| Q2 2020 | $37,285,000 | +269.8% | 391,375 | +248.8% | 0.02% | +220.0% |
| Q1 2020 | $10,083,000 | +906.3% | 112,219 | +387.8% | 0.01% | +400.0% |
| Q4 2018 | $1,002,000 | -24.0% | 23,004 | -0.0% | 0.00% | – |
| Q3 2018 | $1,318,000 | +5.6% | 23,014 | -31.2% | 0.00% | -100.0% |
| Q3 2017 | $1,248,000 | +37.4% | 33,430 | +43.4% | 0.00% | 0.0% |
| Q4 2014 | $908,000 | – | 23,317 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 1,480,060 | $53,563,000 | 85.86% |
| NEXTHERA CAPITAL LP | 217,817 | $7,883,000 | 4.84% |
| Novo Holdings A/S | 903,833 | $32,710,000 | 2.90% |
| SECTORAL ASSET MANAGEMENT INC | 481,765 | $17,435,000 | 1.71% |
| Perceptive Advisors | 589,890 | $21,348,000 | 1.38% |
| RA Capital Management | 318,565 | $11,529,000 | 1.19% |
| OAK RIDGE INVESTMENTS LLC | 1,226,468 | $44,386,000 | 1.15% |
| Granahan Investment Management | 817,149 | $29,573,000 | 0.97% |
| Eventide Asset Management | 428,900 | $15,522,000 | 0.95% |
| QVT Financial LP | 636,764 | $23,044,000 | 0.87% |